Antioxidant Contact Lens
US-2021333436-A1 · Oct 28, 2021 · US
US11754753B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11754753-B2 |
| Application number | US-202117228748-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 13, 2021 |
| Priority date | Apr 27, 2020 |
| Publication date | Sep 12, 2023 |
| Grant date | Sep 12, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A contact lens having antioxidant properties is described as well as methods of manufacturing the same. The contact lens can be present in a sealed contact lens package. The seal contact lens package can include at least a) a plastic base member having a cavity; b) a contact lens packaging solution in the cavity; c) a sterile, unworn contact lens immersed in the contact lens packaging solution in the cavity; and d) a cover that forms a liquid-tight seal with the plastic base member. As an example, the unworn contact lens is a silicone hydrogel contact lens having present therein vitamin E. The vitamin E is non-releasable from the unworn contact lens and the contact lens packaging solution has less than 1 ppm of vitamin E present. The vitamin E is trapped, embedded, absorbed, or non-covalently attached in the unworn contact lens.
Opening claim text (preview).
What is claimed is: 1. An unworn antioxidant contact lens immersed in a packaging solution and sterilely sealed in a package, said contact lens comprising a silicone hydrogel and amount of vitamin E embedded within the silicone hydrogel effective to provide at least a 50% reduction in lipid peroxidation relative to a control contact lens lacking the vitamin E when measured in a TBARS assay, wherein the antioxidant contact lens is free of a bioactive agent having a release profile attenuated by the vitamin E. 2. An unworn antioxidant contact lens immersed in a packaging solution and sterilely sealed in a package, said contact lens comprising a silicone hydrogel and amount of vitamin E embedded within the silicone hydrogel effective to provide at least a 50% reduction in lipid peroxidation relative to a control contact lens lacking the vitamin E when measured in a TBARS assay, wherein the antioxidant contact lens has (a) an ophthalmically-acceptable surface wettability in the absence of a post curing surface treatment and (b) an advancing contact angle that is no more than 10° greater than the control lens. 3. An unworn antioxidant contact lens immersed in a packaging solution and sterilely sealed in a package, said contact lens comprising a silicone hydrogel and 10 μg to 1000 μg of vitamin E embedded in the silicone hydrogel, wherein the antioxidant contact lens (a) has a heat stability that is no greater than a control contact lens lacking the vitamin E and (b) is free of a bioactive agent having a release profile attenuated by the vitamin E. 4. The unworn antioxidant contact lens of claim 1 , wherein the amount of vitamin E is 10 μg to 1000 μg per 25 mg of the antioxidant contact lens when fully hydrated. 5. The unworn antioxidant contact lens of claim 1 having a % equilibrium water content (% EWC) that is no less than 5% that of the control lens. 6. The unworn antioxidant contact lens of claim 1 having between 40% to 60% EWC. 7. The unworn antioxidant contact lens of claim 1 having a lens diameter within ±0.2 mm that of the control lens. 8. The unworn antioxidant contact lens of claim 1 having an advancing contact angle that is no more than 5° greater than the control lens. 9. The unworn antioxidant contact lens of claim 1 wherein the reduction in lipid peroxidation is at least 80%. 10. The unworn antioxidant contact lens of claim 1 , wherein the amount of vitamin E is effective to reduce generation of reactive oxygen species (ROS) from human corneal epithelial cells (HCECs) contacted in vitro with H 2 O 2 relative to the control contact lens when measured in an HCEC viability assay.
Hydrating contact lenses · CPC title
for delivering compositions, e.g. drugs to the eye · CPC title
Contact lenses · CPC title
Contact lenses for the eyes (disinfection or sterilisation of contact lenses A61L12/00) · CPC title
Contact lens cases (A45C11/046 takes precedence) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.